Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
14 nov. 2024 08h00 HE
|
Biora Therapeutics, Inc.
Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain compliance...
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
07 nov. 2024 16h30 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
29 oct. 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive...
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
28 oct. 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today is sharing progress on its development of the...
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
14 oct. 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that Adi Mohanty, CEO of Biora...
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
07 oct. 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will present at...
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
30 sept. 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced an upcoming poster presentation at the...
Biora Therapeutics Achieves ISO 13485 Certification
09 sept. 2024 08h00 HE
|
Biora Therapeutics, Inc.
ISO certification underscores the company’s commitment to quality and excellence
Biora Therapeutics Announces Positive Nasdaq Listing Decision
28 août 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that the company has been granted an...
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
26 août 2024 08h00 HE
|
Biora Therapeutics, Inc.
SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will participate...